In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Co-morbidities in chronic heart failure – time for paradigm shifts in the management of hyperkalaemia and iron deficiency
Session

Event : ESC Congress 2018

Topic : Chronic Heart Failure

  • Session type : Satellite Symposium
  • Date : 25 August 2018
  • Time : 15:30 - 16:30
  • Organised by Charité supported with an educational grant from Vifor

4 presentations in this session

Hyperkalaemia and iron deficiency in chronic heart failure – how important?

Event : ESC Congress 2018

  • Session : Co-morbidities in chronic heart failure – time for paradigm shifts in the management of hyperkalaemia and iron deficiency
  • Speaker : S Anker (Berlin,DE)
  • Organised by Charité supported with an educational grant from Vifor

Advances in hyperkalaemia management – overcoming barriers to optimal renin-angiotensin-aldosterone system inhibitor therapy.

Event : ESC Congress 2018

  • Session : Co-morbidities in chronic heart failure – time for paradigm shifts in the management of hyperkalaemia and iron deficiency
  • Speaker : I Pina (Detroit,US)
  • Organised by Charité supported with an educational grant from Vifor

Iron deficiency management – impact on clinically important outcomes.

Event : ESC Congress 2018

  • Session : Co-morbidities in chronic heart failure – time for paradigm shifts in the management of hyperkalaemia and iron deficiency
  • Speaker : P Van Der Meer (Groningen,NL)
  • Organised by Charité supported with an educational grant from Vifor

Panel discussion and close - Hyperkalaemia and iron deficiency: time for a paradigm change.

Event : ESC Congress 2018

  • Session : Co-morbidities in chronic heart failure – time for paradigm shifts in the management of hyperkalaemia and iron deficiency
  • Speaker : J Butler (Atlanta,US), G Filippatos (Athens,GR), S Anker (Berlin,DE), P Van Der Meer (Groningen,NL), I Pina (Detroit,US)
  • Organised by Charité supported with an educational grant from Vifor

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are